Amprius Technologies falls 7% on third quarter earnings miss

Amprius Technologies (NYSE:AMPX) reported Q3 earnings missing estimates with a loss of $0.02 per share, though revenue of $39.1M beat expectations. Shares fell 7.7% after-hours. The company raised its full-year 2026 revenue outlook to $145M, above analyst forecasts. Gross profit rose 217% YoY to $10.5M, with gross margin improving to 27%. Amprius secured a $75M U.S. Department of War contract and introduced a new battery cell.

Original reporting
Published Nov 10, 2026, 10:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 10, 2026, 10:36 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$AMPX
Bearish
high confidence
Mentioned
$AMPX
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$AMPXBearishHigh
01

Why it matters

The earnings miss triggered a 7% after‑hours decline, but the $75M contract and higher revenue outlook may provide a floor and upside over the next quarters.

02

Market read

First‑report earnings miss with guidance raise and a sizable defense contract; immediate price impact expected.

03

What to watch

Potential future NDAA‑compliant cell production capacity and long‑term government procurement pipeline.

Relevance 7/10Novelty 8/10Timing: after‑hours today

Background

Amprius Technologies (AMPX) is a niche silicon‑anode battery maker that recently secured a major U.S. defense contract.

Company-level read

Ticker impact

$AMPXBearishHigh confidence
Context

Q3 earnings missed EPS expectations and guidance was raised, while a $75M Department of War contract was announced.

Expected impact

likely pressure as the market prices in the earnings miss despite the contract boost

Evidence & confidence

The miss on adjusted EPS (-$0.02 vs -$0.01) triggered a 7% after‑hours drop; however, the $75M contract and higher full‑year revenue guidance may limit the decline.

Market effects

Highlights growing defense‑related demand for silicon‑anode batteries, potentially benefiting peers in the advanced battery space.

U.S. defense spending boost may lift related industrial stocks in the near term.

The contract underscores U.S. strategic push for domestic battery production, a theme of global relevance.

Counterpoint

The contract and raised guidance could outweigh the EPS miss, offering a buying opportunity on dip.

Key entities

  • Amprius Technologies Inc

    U.S. listed battery manufacturer (NYSE:AMPX).

  • U.S. Department of War

    Awarded a $75M contract for NDAA‑compliant battery cells.

Related articles

$AMPXMedAI 8/10

Amprius (AMPX) Q3 2026 Earnings Call Transcript

Amprius reported Q3 2026 revenue of $39.1M, up 83% YoY, raising its full-year target to $145M. The company introduced SiCore 500 cells for aviation and secured a $75M U.S. defense contract. Amprius expanded into maritime vehicles and partnered with U.S. manufacturers for NDAA-compliant production.

$AMPXMedAI 8/10

Amprius Technologies Q3 Earnings Call Highlights

Amprius reported a Q3 net loss of $3.5M, with adjusted EBITDA at -$1M. The company maintained its full-year gross margin forecast of 28% and expects Q4 sales of $43.3M. Amprius is expanding manufacturing to meet demand, with a $75M contract for a U.S. battery production line. It also introduced new products for aviation and deep-sea applications, ending Q3 with $60.7M in cash.

$AMPXMed

Amprius Technologies Reports Third Quarter 2026 Financial Results and Recent

Amprius Technologies, Inc. (AMPX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Amprius Technologies Reports Third Quarter 2026 Financial Results and Recent Business Highlights • Q3 2026 revenue increased 83% year-over-year to $39.1 million • Net loss of $3.5 million, a 10% year-over-year improvement • Increasing 2026 revenue outlook to $145 mil

$AMPXHigh

AMPX Stock Jumps As Defense Deals Supercharge Growth Story

Amprius Technologies Inc. (NYSE: AMPX) shares rose 8.38% on October 21, 2026, driven by U.S. Department of War funding and a partnership with Caminus for battery production. The company secured $75M in funding for a high-energy-density cell plant, with revenue growth but negative margins. Canaccord Genuity initiated coverage with a Buy rating and $14 price target.